Use of preservative-free hyaluronic acid (Hylabak®) for a range of patients with dry eye syndrome: experience in Russia
Open Access
- 1 June 2014
- journal article
- Published by Taylor & Francis Ltd in Clinical Ophthalmology
- Vol. 8, 1169-77
- https://doi.org/10.2147/opth.s47713
Abstract
Artificial tear preparations are important in the management of dry eye syndrome. We present the findings from four recently published studies conducted in Russia assessing Hylabak(®) (marketed as Hyabak(®) in Europe), a preservative-free hyaluronic acid preparation, for the treatment of dry eye syndrome. All studies had an open, noncomparative design, but one compared the findings with those from 25 patients treated with Tear Naturale(®) in previous studies. A total of 134 children and adults were enrolled, and the etiologies of dry eye syndrome included contact lens use, intensive office work, adenovirus eye infection, postmenopausal status, persistent meibomian blepharitis, Sjögren's syndrome, phacoemulsification with intraocular lens implantation, and refractive surgery. The patients were treated with Hylabak for 2 weeks to 2 months. All studies showed that Hylabak resulted in marked improvement as assessed by subjective sensations/complaints, Schirmer's test, Norn's test, impression cytology and biomicroscopy, staining, and tear osmolarity. Greater benefits were also reported compared with Tear Naturale, including a faster onset of action. Hylabak was well tolerated. In conclusion, Hylabak provided rapid and safe relief from the signs and symptoms of dry eye syndrome, as well as improvement in objective measures, in a wide range of patients.Keywords
This publication has 22 references indexed in Scilit:
- Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic reviewOphthalmic and Physiological Optics, 2009
- Rationale for anti-inflammatory therapy in dry eye syndromeArquivos Brasileiros de Oftalmologia, 2008
- The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)The Ocular Surface, 2007
- The Triple Classification of Dry Eye for Practical Clinical UseEuropean Journal of Ophthalmology, 2005
- Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eyeAlbrecht von Graefes Archiv für Ophthalmologie, 2005
- Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eyeBritish Journal of Ophthalmology, 2002
- Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndromeBritish Journal of Ophthalmology, 1999
- Adaptation of the tear film to work in air-conditioned rooms (office-eye syndrome).1994
- Characterization of Water Retentive Properties of HyaluronanCornea, 1993
- Ocular Surface Residence Times of Artificial Tear SolutionsCornea, 1992